4.8 Article

Antiviral CD8+ T Cells Restricted by Human Leukocyte Antigen Class II Exist during Natural HIV Infection and Exhibit Clonal Expansion

期刊

IMMUNITY
卷 45, 期 4, 页码 917-930

出版社

CELL PRESS
DOI: 10.1016/j.immuni.2016.09.015

关键词

-

资金

  1. Bill & Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) [APP1108533]
  2. CFAR Developmental Award (NIH/NIAID) [5P30AI060354]
  3. HHMI International Student Research Fellowship
  4. Research Scholar Career Award of the Quebec Health Research Fund
  5. NIAID [AI104715]
  6. NSF Graduate Research Fellowship
  7. Ragon Institute
  8. Searle Scholars Program
  9. Beckman Young Investigator Program
  10. NIH New Innovator Award [DP2 OD020839]
  11. NIH from NIAID [U24 AI11862-01]

向作者/读者索取更多资源

CD8(+) T cell recognition of virus-infected cells is characteristically restricted by major histocompatibility complex (MHC) class I, although rare examples of MHC class II restriction have been reported in Cd4-deficient mice and a macaque SIV vaccine trial using a recombinant cytomegalovirus vector. Here, we demonstrate the presence of human leukocyte antigen (HLA) class II-restricted CD8(+) T cell responses with antiviral properties in a small subset of HIV-infected individuals. In these individuals, T cell receptor beta (TCR beta) analysis revealed that class II-restricted CD8(+) T cells underwent clonal expansion and mediated killing of HIV-infected cells. In one case, these cells comprised 12% of circulating CD8(+) T cells, and TCR alpha analysis revealed two distinct co-expressed TCRa chains, with only one contributing to binding of the class II HLA-peptide complex. These data indicate that class II-restricted CD8(+) T cell responses can exist in a chronic human viral infection, and may contribute to immune control.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据